Contact Us

Bio-Etc Pte Ltd
60, Paya Lebar Road,
#11-06 Paya Lebar Square,
Singapore 409051

 

Tel: +65 9025 9897
Email: info@bio-etc.com

Social Media

[MCE] NEW! Custom Service for PDCs_ Next Generation of Targeted Therapy

[MCE] NEW! Custom Service for PDCs_ Next Generation of Targeted Therapy

MedChemExpress-Master of Small Molecules (Inhibitors. Screening Libraries. Proteins)

Peptide-drug conjugates (PDCs) have emerged as a promising class of targeted therapeutics. Structurally similar to ADCs, PDCs differ in their homing device, offering unique advantages. A typical PDC is consists of three essential components: a homing peptide, a linker and a cytotoxic payload (Fig 1). The homing peptide includes targeting peptides and cell-penetrating peptides to guide the drug to its intended site. This structure design enables enhanced cell penetration, Reduced immunogenicity and cost-effective synthesis[1].
Figure 1. A schematic structure of peptide–drug conjugates[1].
While only a few PDCs, such as 177Lu-DOTATATE and 177Lu-PSMA-617, have gained approval, most remain in clinical development. Key challenges such as drug stability, efficacy, and administration methods require further optimization to expand therapeutic application, particularly in cancer treatment.
MedChemExpress: Your Partner in PDC Research
MedChemExpress provides a comprehensive range of custom services and products tailored to support your PDC research needs.
Product Service Description
XDC custom service One-stop custom services for ADCs, PDCs, POCs, XDC linkers, and more.
Peptide custom service Custom synthesis for linear peptides, cyclic peptides, fluorescent peptides, and peptide-chelator conjugates.
Product Name Description
Cyclo(RGDyK) A potent and selective αvβ3 integrin inhibitor.
Angiopep-2 hydrochloride A brain peptide vector for conjugation with anticancer agents, ideal for brain cancer research.
7-O-(Amino-PEG4)-paclitaxel A Paclitaxel-linker conjugate for XDC synthesis.
DOTATATE A DOTA-conjugated peptide for PET imaging and peptide receptor radionuclide research.
Reference:
[1] Chem Soc Rev. 2021 Feb 15;50(3):1480-1494.

[button size=” style=’left’ text=’Request Your Quote’ icon=” icon_color=” link=’mailto:info@bio-etc.com’ target=’_self’ color=” hover_color=” border_color=” hover_border_color=” background_color=” hover_background_color=’#9900B2′ font_style=” font_weight=” text_align=” margin=’0 0 0 -200px’]

Tags: